Board Meeting Details

The Board of Directors meeting was held on August 14, 2026, commencing at 12:30 PM and concluding at 2:15 PM.

Financial Results - Standalone (Q1 FY27)

  • Total Revenue: ₹0 (zero)
  • Employee benefit expenses: ₹0.45 lakh
  • Finance costs: ₹38.25 lakh
  • Other expenses: ₹0.70 lakh
  • Total expenses: ₹39.40 lakh
  • Loss before tax: ₹(39.40) lakh
  • Loss after tax: ₹(39.40) lakh
  • Basic & Diluted EPS: ₹(0.26)
  • Paid-up Equity Share Capital: ₹1,490.00 lakh

Financial Results - Consolidated (Q1 FY27)

Includes subsidiary Uniworth Biotech Limited (98.60% holding)

  • Total Revenue: ₹0 (zero)
  • Loss for the period: ₹(39.65) lakh
  • Attributable to owners: ₹(39.10) lakh
  • Attributable to non-controlling interest: ₹(0.55) lakh

Subsidiary Performance

Uniworth Biotech Limited reported:

  • Total revenues: ₹NIL
  • Total net loss: ₹0.25 lakh
  • Comprehensive income: ₹NIL

The subsidiary's financial results were not reviewed by its auditors and were considered not material to the company.

Critical Accounting Notes and Provisions

Significant unprovided receivables and assets:

  • Non-Current Investments: ₹5.12 lakh
  • Other Non-Current Assets: ₹2.83 lakh
  • Trade Receivable: ₹3,010.57 lakh
  • Loan to Body Corporate: ₹0.41 lakh
  • Other Financial Assets: ₹227.73 lakh
  • TDS Receivable: ₹13.95 lakh
  • Miscellaneous Advance: ₹53.39 lakh

Interest provision status:

  • No interest provision made for borrowings from Punjab National Bank, Indusind Bank, and HSBC Bank
  • Interest provision made for Centurion Bank and Punjab & Sind Bank borrowings under simple interest method
  • Impact of compound interest/penal charges could not be ascertained

Regulatory and Compliance Matters

  • Company has applied to Reserve Bank of India for extension/set off of overdue bills and sale of certain investments requiring RBI approval
  • Deferred Tax Assets (Net) not recognized as per Ind AS 12 due to consistent losses and uncertainty of future profits
  • New Labour Codes effective from November 21, 2025, not applicable as company has fewer employees than stipulated threshold

Business Status

Company's business activities have been suspended since long.

Auditor's Review

Khandelwal Ray & Co issued limited review reports for both standalone and consolidated financial results, concluding that nothing came to their attention causing them to believe the statements contain material misstatements, though noting the unprovided provisions mentioned above.

Approval and Compliance

The results were taken on record and approved by the Board of Directors at its meeting held on August 14, 2026, and are presented as per Clause 41 of the Listing Agreement.